GBGürsel Biberoğlu

Gürsel Biberoğlu

*This is an algorithmically generated author record based on publicly available information.

Gürsel Biberoğlu has a total of 37 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • MİTOKONDRİYAL HASTALIK NEDENİYLE TETKİK EDİLEN HASTALARDA M.16189T>C DEĞİŞİKLİĞİNİN METABOLİK SENDROM AÇISINDAN İNCELENMESİ

    by Aslı İNCİ, Filiz Başak CENGİZ ERGİN, İlyas Okur, Gürsel Bi̇beroğlu, Leyla Tümer, Fatih Süheyl Ezgü

    AMAÇ: Metabolik sendrom, obezite, yüksek düzeyde düşük yoğunluklu kolesterol düzeyi (LDL), trigliserit düzeyi (TG) ve insuline duyarlılık ile karakterize olan günümüzde sıklığı giderek artan bir bozukluktur. Metabolik sendromun etiyopatogenezinde hem genetik hem de çevresel nedenlerin rol oynadığı bilinmektedir. Özellikle mitokondriyal DNA’da oluşan m.16189T>C değişikliğinin bu hastalıkla ilişkili olduğu gösterilmiştir. Bu çalışmada mitokondriyal hastalık şüphesi ile başvuran hastalarda saptanan m.16189T>C değişikliğinin klinik ve laboratuvar bulgularının incelenmesi amaçlanmıştır.GEREÇ VE YÖNTEM: Kliniğimize 2019 - 2020 yılları arasında mitokondriyal hastalık şüphesi ile gelen hastalardan m.16189T>C değişikliği olan hastalar çalışmaya alınmıştır. Hastaların klinik ve laboratuvar bulguları mitokondriyal hastalık şüphesi taşıması nedeniyle periferik kandan mitokondriyal DNA izolasyonu yapılmıştır. Yeni nesil DNA dizileme ile tüm mitokondriyal genom DNA dizi analizi yapılarak m.16189T>C değişikliği olan hastalar saptanarak çalışmaya dahil edilmiştir. Bu hastaların klinik ve laboratuvar bulguları metabolik sendrom açısından incelenmiştir.BULGULAR: 1 yıllık süre içinde 55 hastanın 11’inde mitokondriyal genom analizinde m.16189T>C değişikliği saptanmıştır (%20). Fizik muayene bulgularında, hiçbir hastada fazla tartı ve obezite saptanmamıştır. Hastaların glukoz, LDL ve trigliserit düzeyleri normal aralıkta bulunmuştur.SONUÇ: Hasta grubumuzda oldukça yüksek oranda saptanan bu değişikliğin metabolik sendrom ile ilişkisi gösterilememiş ve polimorfizm olarak değerlendirilmiştir. Ancak mitokondriyal hastalık şüphesi ile gelen bu hastaların kullandığı ilaçların, beslenme şekillerinin ve hastalığın patofizyolojisinin bu metabolik sendromu etkileyen çevresel faktörler olabileceği ön görülebilir.

  • The Effect of m.3010G> A Variant on Cyclic Vomiting Syndrome in Turkish Population

    by Filiz Başak CENGİZ ERGİN, Aslı İNCİ, İlyas Okur, Gürsel Bi̇beroğlu, Leyla Tümer, Fatih Süheyl Ezgü

    Giriş ve Amaç: Siklik kusma sendromu (SKS) sık görülen gastrointestinal fonksiyonel bir düzensizliktir. Gastrointestinal fonksiyonel düzensizliklerin mitokondriyal polimorfizmlerle ilişkili olduğu gösterilmiştir. Bu çalışmada, m.3010G>A değişikliğini taşıyan hastalarda klinik bulguların incelenmesi amaçlanmıştır. Gereç ve Yöntemler: Kliniğimize mitokondriyal hastalık şüphesi ile gelen 55 hastadan, periferik kandan mitokondriyal DNA izolasyonu yapılmıştır. Yeni nesil DNA dizileme ile tüm mitokondriyal genom DNA dizi analizi yapılarak m.3010G>A değişikliği olan hastalar saptanmıştır. Bu hastalarda klinik bulgular incelenmiştir. Bulgular: Toplam 55 hastada yapılan mitokondriyal genom analizinde altı farklı hastada m.3010G>A değişikliği saptanmıştır. m.3010G>A değişikliği saptanan bu hasta grubunda SKS ile ilgili klinik bulgular saptanmamıştır. Sonuç: Daha önce yapılan çalışmalarda m.3010G>A değişikliğinin SKS ile ilişkili olabileceği gösterilmiş olsa da bizim çalışmamızda katılan hastalarda bu bulgular bulunmamaktadır. Yine de SKS’nin ileri yaşlarda da ortaya çıkabileceği göz önünde bulundurulmalı ve yakın takip edilmelidir.

  • Open Access

    PROPIONYLCARNITINE AND FREE CARNITINE ARE NEW BIOMARKERS IN THE FOLLOW-UP PERIOD OF MUCOPOLYSACCARIDOSIS TO SCREEN OXIDATIVE STRESS

    by Aslı İNCİ, Asburce Olgac, Betül Genç Deri̇n, Gürsel Bi̇beroğlu, İlyas Okur, Fatih Süheyl Ezgü, Leyla Tümer

    Amaç: Mukopolisakkaridoz (MPS) hastalarında oksidatif stresi taramak için uygulanabilir ve kolay bir prosedür mevcut değildir. Bu çalışmada amaç, MPS'deki oksidatif belirteçlere göre serbest karnitin (SK) ve propiyonilkarnitinin (PK) antioksidatif özelliklerini göstermek ve hasta takibinde basit ve kolay bir yöntem olarak kullanmaktır. Gereç ve Yöntem: Çalışmaya, 27 MPS hastasında ve 24 sağlıklı gönüllü dahil edilerek bu hastalarda SK ve PK, antioksidatif belirteç olarak tandem kütle spektroskopisi kullanılarak çalışıldı ve malondialdehit (MDA), ise oksidatif belirteç olarak kullanıldı. Bulgular: MPS hastalarında, PC ve FC seviyeleri önemli ölçüde azalırken, MDA seviyeleri sağlıklı gönüllülere göre daha yüksek bulundu. Enzim yerine koyma tedavisi alan MPS hastaları ile tedavi edilmeyen MPS hastaları karşılaştırıldığında, gruplar arasında anlamlı bir fark saptanmadı. Çalışma, MDA'nın PK ile anlamlı oranda ters orantılı olduğu bulundu (r = –0.402, P = 0.003). PK'nin MDA ile anlamlı bir korelasyona sahip olması dikkat çekiciydi. Sonuç: MPS hastalarının daha yüksek MDA düzeylerine ve daha düşük PK ve SK düzeylerine sahip olduğunu göstermiştir, buna göre MPS hastalarının oksidatif yönde bir dengesizliğe sahip olduğunu ortaya koymuştur. PK ve SK, MPS hastalarının takibinde uygulanabilir bir yöntem olabilir ve hastaların enzim yerine koyma ve/veya antioksidan ilaçların tedavilerinin cevabının gözlemek için yeni biyobelirteçler olarak kullanılabilir. Background:There is no applicable and easy procedure to screen oxidative stress in mucopolysaccaridosis (MPS) patients. The aim herein was to show the antioxidative properties of free carnitine (FC) and propionylcarnitine (PC) with respect to oxidative markers in MPS and use a simple and easy method in patient follow-up. Material-method:FC and PC were studied as an antioxidative marker using tandem mass spectroscopy and malondialdehyde (MDA) was studied as an oxidative marker in 27 MPS patients and 24 healthy volunteers. Results:While the PC and FC levels were significantly decreased, the MDA levels were higher in the MPS patients than in the healthy volunteers.When compared between the enzyme-treated MPS patients and untreated MPS patients, there were no significant differences between the groups. MDA was found to inversely correlated with PC (r =–0.402, P=0.003).It was noteworthy that PC had a significant correlation with MDA. Conclusion:The findings revealed that the affected patients had higher MDA levels and lower PC and FC levels, indicating an imbalance through the oxidative side. An applicable method of FC and PC measurement could be used to screen patients, considering them as new antioxidative markers in the patient follow-up period for the response of enzyme replacement therapy and/or antioxidant drugs.

  • Congenital defects of glycosylation: Novel presentations with mainly neurological involvement and variable dysmorphic features

    by Aslı İnci, Başak Cengiz, Gürsel Biberoğlu, İlyas Okur, Ebru Arhan, Ali Yusuf Öner, Çiğdem Seher Kasapkara, Aynur Küçükçongar, Leyla Tümer, Fatih Ezgu

    The pathophysiology of congenital defects of glycosylation (CDG) is complex and the diagnosis has been a challenge because of the overlapping clinical signs and symptoms as well as a large number of disorders. Isoelectric focusing of transferrin has been used as a screening method but has limitations. Individual enzyme or molecular genetic tests have been difficult to perform. In this study, we aimed to describe CDG patients who were referred to from different departments either without a preliminary diagnosis or suspected to have a genetic disorder other than CDG. The patients were diagnosed mainly with a 450 gene next‐generation DNA sequencing panel for inborn errors of metabolism, which also included 25 genes for CDG. A total of 862 patients were investigated with the panel, whereby homozygous (10) or compound heterozygous (4) mutations were found in a total of 14 (1.6%) patients. A total of 13 different mutations were discovered, 10 of them being novel. Interestingly, none of the patients was suspected to have a CDG before referral. This report expands the clinical/laboratory findings in patients with CDG and stresses on the fact that CDG should be in the differential list for pediatric patients presented with nonspecific dysmorphic features and neurological delays/regression. Also, next‐generation DNA sequencing with panel approach was noticed to have a significant diagnostic potential in patients presented with nonspecific neurologic and dysmorphic findings.

  • Open Access

    A rare urea cycle disorder in a neonate: N-acetylglutamate synthetase deficiency

    by Asburce Olgac, Çiğdem S Kasapkara, Mustafa Kilic, Betul Emine Derinkuyu, Ebru Azapagasi, Selman Kesici, Gürsel Biberoğlu, Ahmet Ozyazici, Meryem Karaca, Johannes Haberle

    Urea cycle disorders (UCD), are genetically inherited diseases that may have a poor outcome due to to profound hyperammonemia. We report the case of a baby girl diagnosed as N-acetylglutamate synthase (NAGS) deficiency. The patient was evaluated due to diminished sucking and hypotonicity. Physical examination showed hepatomegaly. Complete blood count, biochemical values and blood gas analyses were normal, acute phase reactants were negative. Further laboratory analyses showed no ketones in blood and highly elevated ammonia. Metabolic tests were inconclusive. Emergency treatment was initiated immediately and she was discharged on the 15th day of admission. NAGS deficiency was confirmed by DNA-analysis. She is now without any dietary restriction or other medication, except N-carbamylglutamate (NCG). NAGS deficiency is the only UCD which can be specifically and effectively treated by NCG. Early recognition of disease will lead to early treatment that may prohibit devastating effects of hyperammonemia.


  • Open Access

    Posterior fossa horns; a new calvarial finding of mucopolysaccharidoses with well-known cranial MRI features

    by Çağrı Damar, Betül Emine Deri̇nKuyu, Muazzez Asburçe Bike Olgaç Kiliçkaya, Mehmet Öztürk, Çiğdem Öztunali, Ayşe Gül ALIMLI, Öznur Leman Boyunağa, Murat Uçar, Fatih Süheyl Ezgü, Leyla Tümer, et al.

    Background/aim: Mucopolysaccharidoses (MPS) are a group of hereditary metabolic diseases. The aim of this study was to share the previously unreported calvarial finding of internal hypertrophy of the occipitomastoid sutures (IHOMS) together with some other well-known cranial MRI findings in this patient series. Materials and methods: A retrospective evaluation was conducted of 80 cranial MRIs of patients who had been diagnosed and followed up with MPS from 2008 to 2019 in our center. Of these patients, 11 had Hurler, 14 had Hunter, 24 had Sanfilippo, 15 had Morquio, 14 had Maroteaux-Lamy, and 2 had Sly disease. The cranial MRIs were assessed in two main groups as parenchymal intradural cranial MRI findings and extradural calvarial findings. Results: The most common parenchymal intradural cranial MRI findings were white matter signal alterations (n = 51, 63%) and perivascular space enlargements (n =39, 48%). The most common extradural calvarial findings were J-shaped sella (n = 45, 56%) and tympanic effusion (n = 44, 55%). Although IHOMS was defined in a relatively small number of the patients (n = 12, 15%), the prevalence rate was high in MPS type I (n = 6, 54%). Conclusion: The abnormal cranial MRI findings of the MPS patients, including the newly identified IHOMS, may provide diagnostic clues to differentiate the type of the disease in radiological imaging.


  • Obez Türk çocuklarında plazma adiponektin ve plazminojen aktivatör inhibitor-1 düzeyleri

    by Ferda Ozbay, Leyla Tumer, Fatih Süheyl Ezgü, Asburce Olgac, Alev Hasanoglu

    Introduction: It is known that obesity itself is a risk factor for atherosclerosis. Dyslipidemia, insulin resistance and the deficiency of the adiponectin (ADPN), which is an adipocytokine increasing the insulin sensitivity, are the main factors known for their relations with the obesity and atherosclerosis. This study aimed to determine the levels of plasma ADPN in obese children and its relationship with several other factors associated with atherosclerosis. Materials and Method: Plasma levels of ADPN, plasminogen activator inhbitor-1 (PAI-1), lipids and insulin and blood hemoglobin A1c (HbA1c) levels were measured and their relations with each other were determined in 30 obese and 28 healthy children. Oral glucose tolerance test (OGTT) was performed to obese children and ADPN and PAI-1 levels were rechecked at the second hour of OGTT. Results: In obese children, the basal ADPN and PAI-1 levels were lower, than their levels obtained 2 hours after the OGTT. Basal ADPN levels showed negative correlation with the body mass index, and triglyceride, very low density lipoprotein (VLDL) and insulin levels. Negative correlation was also detected between the postprandial PAI-1 and high density lipoprotein (HDL), and between plasma ADPN and insulin and triglyceride levels. While the changes in triglyceride and insulin levels negatively affected the ADPN, the changes in HbA1c affected ADPN positively. Conclusion: Our study indicates that, plasma ADPN level can be used as a follow up marker for atherosclerosis.

  • Diagnosis of glycine encephalopathy in a pediatric patient by detection of a GLDC mutation during initial next generation DNA sequencing

    by Fatih Ezgu, Bahattin Çiftci, Burcu Topçu, Gülcan Adıyaman, Hatice Gökmenoğlu, Aynur Küçükçongar, Çiğdem Kasapkara, Gürsel Biberoğlu, Leyla Tümer, Alev Hasanoğlu

    Early diagnosis for metabolic encephalopathy caused by inborn errors of metabolism is very important for the initiation of early treatment and also for prevention of sequela. Metabolic encephalopathy in the form of seizures can result from many inborn errors of metabolism and considering the large number of disorders causing metabolic encephalopathy, enzyme assays or conventional molecular tests are expensive and take considerably long period of time which results in delayed treatment. In our center we have used next generation DNA sequencing technology as an initial diagnostic test to look for about 700 disorders at the same time for the etiologic diagnosis of a 4-month-old female infant suffering from intractable seizures. The patient was found to have glycine encephalopathy resulting from a previously defined mutation in the GLDC gene. The diagnostic result was obtained much sooner than other conventional investigations. Up to our knowledge, this would be the first case with glycine encephalopathy in the literature who was approached by this novel panel method initially. Although currently, classical evaluation methods such as physical examination, biochemical and conventional molecular investigations are still accepted as the gold standards to clarify the etiology of the metabolic encephalopathy it is obvious that next generation sequence analysis will play a very significant role in the future.